BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 26096891)

  • 21. Glutamate transporter expression and function in human glial progenitors.
    Maragakis NJ; Dietrich J; Wong V; Xue H; Mayer-Proschel M; Rao MS; Rothstein JD
    Glia; 2004 Jan; 45(2):133-43. PubMed ID: 14730707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sumoylation of the astroglial glutamate transporter EAAT2 governs its intracellular compartmentalization.
    Foran E; Rosenblum L; Bogush A; Pasinelli P; Trotti D
    Glia; 2014 Aug; 62(8):1241-53. PubMed ID: 24753081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective Effects of the Glutamate Transporter Activator (R)-(-)-5-methyl-1-nicotinoyl-2-pyrazoline (MS-153) following Traumatic Brain Injury in the Adult Rat.
    Fontana AC; Fox DP; Zoubroulis A; Mortensen OV; Raghupathi R
    J Neurotrauma; 2016 Jun; 33(11):1073-83. PubMed ID: 26200170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequences of the non-coding RNA, NTAB, are contained within the 3'-UTR of human and rat EAAT2/GLT-1 transcripts and act as transcriptional enhancers.
    Bette S; Unger T; Lakowa N; Friedrich M; Engele J
    Cell Mol Neurobiol; 2011 Apr; 31(3):393-9. PubMed ID: 21110225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.
    Takahashi K; Foster JB; Lin CL
    Cell Mol Life Sci; 2015 Sep; 72(18):3489-506. PubMed ID: 26033496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homeostasis of the astrocytic glutamate transporter GLT-1 is altered in mouse models of Lafora disease.
    Muñoz-Ballester C; Berthier A; Viana R; Sanz P
    Biochim Biophys Acta; 2016 Jun; 1862(6):1074-83. PubMed ID: 26976331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial Loss of the Glutamate Transporter GLT-1 Alters Brain Akt and Insulin Signaling in a Mouse Model of Alzheimer's Disease.
    Meeker KD; Meabon JS; Cook DG
    J Alzheimers Dis; 2015; 45(2):509-20. PubMed ID: 25589729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative splicing of the glutamate transporter EAAT2 (GLT-1).
    Meyer T; Münch C; Knappenberger B; Liebau S; Völkel H; Ludolph AC
    Neurosci Lett; 1998 Jan; 241(1):68-70. PubMed ID: 9502218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Over-expression of the human EAAT2 glutamate transporter within neurons of mouse organotypic hippocampal slice cultures leads to increased vulnerability of CA1 pyramidal cells.
    Selkirk JV; Stiefel TH; Stone IM; Naeve GS; Foster AC; Poulsen DJ
    Eur J Neurosci; 2005 Apr; 21(8):2291-6. PubMed ID: 15869527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.
    Sheldon AL; Robinson MB
    Neurochem Int; 2007; 51(6-7):333-55. PubMed ID: 17517448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloning of a new form of EAAT2/GLT-1 from human and rodent brains.
    Lee A; Klinkradt S; McCombe PA; Pow DV
    Neurosci Lett; 2022 May; 780():136637. PubMed ID: 35439550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutamate transporter EAAT2: a new target for the treatment of neurodegenerative diseases.
    Lin CL; Kong Q; Cuny GD; Glicksman MA
    Future Med Chem; 2012 Sep; 4(13):1689-700. PubMed ID: 22924507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic dys-regulation of astrocytic glutamate transporter EAAT2 and its implications in neurological disorders and manganese toxicity.
    Karki P; Smith K; Johnson J; Aschner M; Lee EY
    Neurochem Res; 2015 Feb; 40(2):380-8. PubMed ID: 25064045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glial Glutamate Transporter-Mediated Plasticity: System x
    Dahlmanns M; Dahlmanns JK; Savaskan N; Steiner HH; Yakubov E
    Front Biosci (Landmark Ed); 2023 Mar; 28(3):57. PubMed ID: 37005761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substrate exchange properties of the high-affinity glutamate transporter EAAT2.
    Dunlop J
    J Neurosci Res; 2001 Nov; 66(3):482-6. PubMed ID: 11746366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of excitatory amino acid transporter 2 (EAAT2) in epilepsy and other neurological disorders.
    Alijanpour S; Miryounesi M; Ghafouri-Fard S
    Metab Brain Dis; 2023 Jan; 38(1):1-16. PubMed ID: 36173507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The in vitro uptake of glutamate in GLAST and GLT-1 transfected mutant CHO-K1 cells is inhibited by manganese.
    Mutkus L; Aschner JL; Fitsanakis V; Aschner M
    Biol Trace Elem Res; 2005 Dec; 107(3):221-30. PubMed ID: 16286678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-regulation of brain-enriched miR-107 promotes excitatory neurotoxicity through down-regulation of glutamate transporter-1 expression following ischaemic stroke.
    Yang ZB; Zhang Z; Li TB; Lou Z; Li SY; Yang H; Yang J; Luo XJ; Peng J
    Clin Sci (Lond); 2014 Dec; 127(12):679-89. PubMed ID: 24943094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early loss of the glutamate transporter splice-variant GLT-1v in rat cerebral cortex following lateral fluid-percussion injury.
    Yi JH; Pow DV; Hazell AS
    Glia; 2005 Jan; 49(1):121-33. PubMed ID: 15390098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional and morphological characterization of glutamate transporters in the rat locus coeruleus.
    Medrano MC; Gerrikagoitia I; Martínez-Millán L; Mendiguren A; Pineda J
    Br J Pharmacol; 2013 Aug; 169(8):1781-94. PubMed ID: 23638698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.